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Abstract
Background: Resistance to most antimalarial drugs has encouraged the use of herbal preparations along with prescribed
orthodox drugs.
Objective: To investigate effect of  co-administration of  aqueous extract of  T. occidentalis leaves; commonly used as
antimalarial and haematinic agent in Nigeria and artesunate using P. berghei animal model.
Methods: In vivo curative antiplasmodial effect of T. occidentalis (200mg/kg) alone and combination with artesunate
(2mg/kg) were evaluated using albino mice infected with 106 parasitized erythrocytes of  P. berghei intraperitoneally. The
haematological parameters: haemoglobin level, red blood cells and white blood cells and packed cell volume were monitored
using standard methods.
Results: Aqueous extract of T. occidentalis, artesunate and the combination gave 72.17±4.07%, 70.43± 4.27% and 85.43±
3.65% reduction in parasitaemia after 48hours respectively. A significant enhancement of  the PCV was obtained with the co-
administration of  artesunate and aqueous extract (p< 0.01). Similar trends were also observed with heamatological parameters
at 72hours of administration.
Conclusion: This study revealed a synergistic effect of  the co-administration on parasite clearance rate of  P. berghei infection
in mice, with a significant enhancement of haematological parameters within 48 hours of administration. This indicates a
rapid rate of recovery from plasmodial infections with the co-administration.
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Introduction
Malaria is a life threatening parasitic infection caused
by Plasmodium species and the most virulent to man
is Plasmodium falciparum. Malaria is a common disease
in most tropical countries with over 120 million cases
reported annually resulting in the death of about 3
million people annually1. The disease which is
endemic in Sub-Saharan Africa with children under
the age of five and pregnant women at risk 2 is
among the top three deadly communicable diseases
and it is the most deadly tropical disease despite
various efforts towards its control 3. The provision
of effective chemoprophylaxis and treatment of
malaria is still a major problem in tropical countries
4.
Chemotherapeutic management of malaria
has been bedevilled by various problems as a result
of development of resistance to most of the earlier
drugs like chloroquine, amodiaquine and other drugs
5. This has led to the development of newer drugs
of which artemisinine derivatives have been widely
accepted. Artemisinin antimalarial drugs derived from
the extract of a Chinese herb ‘Quinhaosu’ used for
the treatment of fevers have in the past three decades
been reported to be efficacious in clinical
management of chloroquine-resistant malaria 6, 7.
Artesunate, a prodrug of dihydroartemisinine is
about the most widely used of all the artemisinin
derivatives. It is the most rapidly acting of  the
artemisinin derivatives, exhibiting rapid absorption
after oral and intramuscular administration and rapid
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elimination8. Artesunate have been reported to be
effective in uncomplicated, severe and multidrug
resistant malaria. It is a key member of the artemisinin
– combination therapy (ACT) currently approved
for the management of  malaria by WHO.
The current regimen for the management
of malaria comprising the use of artemisinin
derivatives with other antimalarial agents is currently
having problems with implementation in developing
countries due to affordability and accessibility
constraints. The rising cost of  prescription drugs in
the maintenance of personal health has resulted in
increased interest in the use of medicinal plants as a
re-emerging health aid 9. This has led to re-awakened
interest in the exploration of medicinal plants for
the management of malaria. Herbal medicine is
becoming increasingly popular in both developed
and developing countries10, 11.
The level of confidence placed on herbal preparations
has encouraged their use along with prescribed
orthodox drugs and over-the-counter (OTC) drugs
for various diseased conditions12, 13, 14, 15, 16.
Telfarias occidentalis, a member of  the
Cucurbitaceae family popularly known as fluted
pumpkin is highly reputed in traditional medicine
practice in Nigeria 17. It is commonly called Ugu in
most parts of Nigeria with different parts of the
plant being employed for various diseased conditions
ranging from convulsion, malaria and anaemia18. The
leaves are rich in essential and non-essential amino
acids, vitamins and minerals21. Aqueous extracts of
T. occidentalis leaves is used locally in Nigeria as
antimalaria and haematinic agent22.
The aqueous extract of the leaves have been
reported to possess significant enhancement of
haematological parameters (erythrocyte count,
packed cell volume, haemoglobin concentration and
white blood cell count), antiparasitic effect on P.
berghei infected mice as well as hypoglycaemic activity
23, 24, 25. In view of the increasing rate at which herbal
preparations are used with orthodox medicines, there
is the need to evaluate the clinical implications of
co-administration of herbal preparations with
orthodox medicines.
Earlier reports on the enhancement of
heamatological parameters as well as antiparasitic
activity of aqueous extract of the leaves of T.
occidentalis prompted this study. The study was aimed
at evaluating the possible clinical implications of the
co-administration of T. occidentalis with artesunate in
order to proffer support or question the feasibility
of developing a cost–effective and efficacious
management for malaria using a combination of
herbs and antimalarials especially in poor resourced
economies.
This investigation evaluated the effect of the
co-administration of crude aqueous extract of T.
occidentalis leaves; at an earlier reported antiparasitic
concentration of 200mg/Kg body weight and
artesunate at 2mg/Kg body weight on the
antiplasmodial activity and haematological
parameters using P. berghei animal model.
Methods
Plant material
Fresh leaves of T. occidentalis (fluted pumpkin) were
collected from a local farm within the University of
Ibadan; the plant was identified and authenticated
by Mr. D. Esimekhwai of  the Department of
Botany, University of  Ibadan. A voucher specimen
was deposited in the Herbarium of the Department
with voucher number UIH 22357.
Preparation of aqueous extract
The extracts were prepared as earlier described by
Salman, et al, 2008 25. Briefly, fresh leaves were air-
dried at room temperature (28 – 30oC). The dry
leaves were reduced to coarse powder by grinding.
200g of the powdered leaves was soaked in 4L of
distilled water for 48hrs with mixing at intervals, after
which it was filtered using muslin cloth. The filtrate
was concentrated using rotary evaporator followed
by drying in vacuum oven at 50oC. The dry thick
slurry was transferred to dry sample bottle and stored
at -5oC until use.
Identification and assay of artesunate powder
The melting point, thin layer chromatography and
chemical content determination was carried out
according to the official method26.
Animals and Parasite
Male and female albino mice weighing 20.2 ± 2.1g
(18 – 22g) obtained from Central Animal House,
College of Medicine, University of Ibadan were use
for the study. The mice were separated into male
and female, maintained under standard laboratory
conditions [Temperature: 25 – 30oC, 12 hour light
and 12hour darkness cycles] and fed with mice pellet
diet (Ladokun Farms, Nigeria) with water ad libitum.
The animal study was in accordance with the National
Institute of Health Guidelines for Care of
Laboratory animals. The animals were allowed to
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acclimatize for a week prior to random distribution
into experimental groups.
Plasmodium berghei, chloroquine sensitive ANKA strain
was obtained from Prof. O. G. Ademowo of  the
Institute for Advanced Medical Research and Training
(IAMRAT), University of Ibadan and maintained
by passage in mice.
In vivo antimalarial studies
Inoculums preparation and parasitaemia load
determination
Standard inoculum was prepared from a donor
mouse with Chloroquine–sensitive NK-65 strain of
P. berghei parasitized erythrocytes. The donor mouse
was previously infected with the parasite
intraperitoneally through standard procedure, and
was kept under standard laboratory conditions
[Temperature: 25 – 30oC, 12 hour light and 12hour
darkness cycles] with food and water “ad libitum”
until the desired level of parasitemia is achieved.
Infected blood from the donor mouse was obtained
by cardiac puncture after anaesthesia with
chloroform. Microscopic examination of  the thin
blood film was used to establish parasitaemia.
Each mouse to be used for the test was infected
with a standard inoculum of 106 parasitized
erythrocyte suspension in normal saline (0.2ml) from
a donor mouse. The inoculum was prepared based
on the percentage parasitaemia and the number of
erythrocytes counted per microlitre.
Curative treatment (Rane test)
This was carried out according to an earlier reported
method 27. The study design used sixty-four albino
mice which were randomized into eight groups of
eight animals per group (male and female).
The parasitized groups were intraperitoneally infected
with 106 parasitized erythrocytes with oral treatment
commencing on day 4 post inoculations and daily
till day 7.
The animals were grouped as follows;
ATocP - Artesunate + Aqueous Extract of  T.
occidentalis in P. berghei infected mice,
TocP - Aqueous Extract of  T. occidentalis only in P.
berghei infected mice,
AToc - Artesunate + Aqueous Extract of  T.
occidentalis in healthy mice,
Toc - Aqueous Extract of  T. occidentalis in healthy
mice,
CA - Artesunate in healthy mice,
CN - Healthy mice given only water.
CAP - Artesunate alone in P. berghei infected mice,
CNP - P. berghei infected mice given only water,
Animal in ATocP were given the extract at 200mg/
kg body weight in combination with artesunate at
2mg/kg body weight, while TocP were given the
extract at 200mg/kg only. CAP were given artesunate
at 2mg/kg only, while CNP were given water only
and served as positive control.
The other four groups which were healthy animals
were similarly treated; AToc were administered the
extract and artesunate, Toc were administered only
extract alone, CA were administered artesunate
alone, while CN were given only water serving as
negative control.
Tail snips was used to prepare thin blood films
starting from day 4 post inoculation on a daily basis
till day 7 (3rd day of treatment) and then on the 14th
day post inoculation (10th day of  treatment). Tail
blood films were prepared, fixed in methanol,
stained with Giemsa stain (4%w/v) for 20 minutes
and examined microscopically under oil immersion.
Percentage reduction in parasitemia was calculated
using the equation below;
% Reduction in Parasitemia = [(Initial Load - Load at
Time T)] / Initial Load x 100
Haematological parameters
Blood samples were collected from the mice through
the retro-orbital puncture into heparinised sample
bottles at the end of the study i.e. four mice per
group at 3rd day of treatment and the remaining
four mice at the 10 th day of treatment.
Haematological parameters; packed cell volume
(PCV), red blood cell count (RBC), white blood cell
count (WBC), neutrophils, eosinophils and
Haemoglobin level (Hb) were evaluated in
accordance with standard procedures. Haemoglobin
levels were measured using the
cyanomethaemoglobin method, red blood and
white blood cell counts were done using
haemocytometer, while PCV was measured by the
conventional method of filling capillary tubes with
blood and centrifuging using microhaematocrit
centrifuge.
Statistical analysis
Data were expressed as mean ±S.E.M. Statistical
significance was determined using Student t-test, p
< 0.05 was considered significant.
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Results
Phytochemical screening of the aqueous extract of
T. occidentalis leaves showed the presence of alkaloids,
cardenolides, anthraquinones, saponins, flavonoids
and tannins. Identification and assay of  the pure
artesunate powder confirmed the purity of  the drug
with a percentage chemical content of 106.24 ± 0.36
%w/v.
The effect of the aqueous extract of T.
occidentalis on the ability of artesunate to clear
parasiteamia due P. berghei is presented in figure 1.
Aqueous extract of T. occidentalis and artesunate gave
72.17± 4.07% and 70.43± 4.27% reduction in
parasitemia by the 2nd day of administration
respectively, while the combination gave 85.43±
3.65% reduction.  The co-administration of aqueous
extract of T. occidentalis with artesunate and artesunate
alone gave a total clearance of parasitemia (100%)
by the 3rd day of administration, while the aqueous
extract of T. occidentalis alone gave 85.52± 3.62%
reduction in parasitemia. All the treatments gave
100% clearance by the 10th day of administration.
Figure 1: % Reduction in Parasiteamia showing
the effect of  Aqueous Extract of  T.  occidentalis
on Artesunate in P.berghei berghei infected
mice.
Evaluation of the haematological parameters
showed an insignificant enhancement of the PCV
by T. occidentalis on the 3rd day of administration in
the diseased state. PCV of 33.3± 1.45% was
obtained for the control group in the presence of
infection (CNP), while 37 ± 0.58% was obtained
for the aqueous extract of  T. occidentalis (TocP).
Similarly, 42.5 ± 0.96% was obtained in the absence
of infection (CN) while 44.5 ± 0.65% was obtained
after the administration of  the extract (Toc) (table
1).
Table 1: Some haematological parameters obtained after administration of  aqueous extract of  T.
occidentalis with Artesunate for 3 and 10 days to P.berghei infected and healthy mice. (Data expressed
as Mean± S.E.M)
Animal Groups PCV (%) Hb. Concentration            RBC count (1012/L) (g/dL)
3 Days 10 Days 3 Days 10 Days 3 Days 10 Days
ATocP 42.0 ± 2.31a 24.0 ± 2.00b 13.3 ± 0.87 7.3 ± 0.50 6.1 ± 0.22 3.4 ± 0.13
TocP 37.0± 0.58 a 40.3 ± 1.69b, c         11.6 ± 0.12 12.9 ± 0.67 6.1 ± 0.12 6.7 ± 0.24
CAP 34.0 ± 1.08 a 21.5 ± 6.50c 10.6 ± 0.41 6.7 ± 2.0 5.5 ± 0.27 2.6 ± 1.56
CNP 33.3 ± 1.45 23.0 ± 5.51 10.7 ± 0.48 7.1 ± 2.10 5.3 ± 0.24 3.3 ± 1.21
AToc 46.0 ± 1.08 46.0 ± 1.41 14.6 ± 0.35 14.8 ± 0.42 7.5 ± 0.44 7.6 ± 0.31
Toc 44.5 ± 0.65 46.5 ± 2.50 14.2± 0.32 14.6 ± 0.95 7.3 ± 0.14 8.0 ± 0.42
CA 46.0 ± 1.23 35.0 ± 13.00 14.8 ± 0.51 11.2 ± 4.40 7.6 ± 0.18 5.6 ±2.31
CN 42.5 ± 0.96 46.5 ± 1.50 13.4± 0.15 15.2 ± 0.40 7.0 ± 0.15 7.5 ± 0.18
Values are expressed as the mean ± SEM, with significance at p < 0.01 for a, while b and c was p < 0.05
compared with the control; n = 4.
Note: ATocP: Artesunate + Aqueous Extract of  T. occidentalis in P. berghei infected mice, TocP: Aqueous Extract of  T.
occidentalis only in P. berghei infected mice, CAP: Artesunate alone in P. berghei infected mice, CNP: P. berghei infected mice
given only water,
AToc:  Artesunate + Aqueous Extract of  T. occidentalis in healthy mice, Toc: Aqueous Extract of  T. occidentalis in healthy
mice, CA: Artesunate in healthy mice, CN: Healthy mice given only water.
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However, the co-administration of artesunate with
the aqueous extract (ATocP) gave a significant
enhancement of the PCV when compared with
artesunate (CAP) and extract alone (TocP) at day 3
(p < 0.01) (table 1).
Similar trend was also observed with Haemoglobin
concentration, RBC, WBC, platelet count, neutrophils
and eosinophils (tables 1 and 2).
The results obtained by the 10th day of
administration gave a PCV of 40.3 ± 1.69, 21.5±
6.5 and 24.0 ± 2.0% for aqueous extract of T.
occidentalis, artesunate and combination of T.
occidentalis and artesunate respectively in the diseased
state. This indicates a significant enhancement of the
PCV with extract alone (p < 0.05) and a non-
significant increase with the combination of T.
occidentalis with artesunate (p > 0.05) (table 1) when
compared with the control diseased state (CNP).
On the other hand, the absence of infection showed
a non-significant difference in the haematological
parameters for the extract alone, combination of
artesunate and extract and the control group, while
artesunate alone gave lower values. Similar trends
were observed for Haemoglobin level, RBC, and
WBC (table 2).
Table 2: Other haematological parameters obtained after administration of  aqueous extract of  T.
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Discussion
This investigation further confirm that T. occidentalis
leaves contains secondary metabolites like alkaloids,
saponins, tannins anthraquinones which is in agreement
with earlier reports on the plant agent 22. Also, chemical
content of the pure artesunate used was 106.24 ±
0.36%w/v, which is line with the expected official
specification for artesunate 26.
The prevention of severe malaria induced anaemia
necessitates rapid treatment of symptomatic high
density parasitaemia, as well as reduction of
asymptomatic parasite prevalence and to provide
recovery period for the replacement of infected of
erythrocytes28. The need for appropriate drug
management to achieve this is crucial as anaemia
associated with malaria represents a major cause of
childhood mortality in sub-Saharan Africa29. This
investigation reported a reduction in the percentage
parasitemia following administration of aqueous
extract of T. occidentalis, artesunate and the co-
administration of the two by the 48hours of
administration. This indicates that T. occidentalis and
artesunate are antiplasmodic while the co-administration
of the two agents gave a synergistic antiplasmodic
effect on P. berghei infection in mice. This result is
comparable to the significant enhancement of
antimalarial effect reported when Vernonia amygdalina
and Khaya grandifolia were co-administered with other
antimalarial drugs such as chloroquine and halofantrine
respectively28, 30.
It is worthy of note that there was an
enhancement of haematological indices by aqueous
extract of T. occidentalis both on haematological
parameters in healthy rats as showed in (table 1), this
is in agreement with earlier report23. Similar
enhancement of  haematological indices was observed
with the co-administration of T. occidentalis with
artesunate as it reversed the observed anaemia induced
by plasmodial infection. This was evident by significant
higher packed cell volume (PCV), haemoglobin level
(Hb) and red blood cell (RBC) count in the T.
occidentalis-artesunate combination than those obtained
for the artesunate (CAP) and T. occidentalis aqueous
extract alone (TocP) (p < 0.05, ANOVA) in the infected
animals.
This showed that the co-administration of aqueous
extract of T. occidentalis and artesunate have a
synergistic effect on the rate of parasite clearance of
P. berghei infection in mice with a significant
enhancement of haematological parameters within
three days of administration. This indicates an
advantage of rapid rate of recovery from plasmodial
infections when the two are co-administered.
This observed significant enhancement of
haematological parameters in the diseased state by the
third day of the aqueous extract of T. occidentalis
showed the possible prospect of the combination in
the treatment of acute malaria in children.
Furthermore, administration of  T. occidentalis aqueous
extract alone in the diseased state for ten days revealed
a significant enhancement of haematological indices
when compared with artesunate alone. T. occidentalis in
combination artesunate is beneficial in the management
of  plasmodial infection, in poor resourced economies.
Conclusion
It can be concluded that the combined effect of
artesunate and aqueous extract of T. occidentalis
enhanced rate of parasitemia clearance and enhanced
haematological indices in anaemia induced by
plasmodial infection. The combination is beneficial in
the management of the infection as it will ensure rapid
recovery especially in poor resourced economies.
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